Volume 16 (2019)
Volume 15 (2018)
Volume 14 (2017)
Volume 13 (2016)
Volume 12 (2015)
Volume 11 (2014)
Volume 10 (2013)
Volume 9 (2012)
Volume 8 (2011)
Volume 7 (2010)
Volume 6 (2009)
Volume 5 (2008)
Volume 4 (2007)
Volume 3 (2006)
Volume 2 (2005)
Volume 1 (2004)
1. Anti-Cardiolipin and Anti-Neutrophil Cytoplasmic Antibodies in Iranian Patients with Behcet's Disease

Mohammad Reza Ataollahi; Elham Aflaki; Mohammad Ali Nazarinia; Saeedeh Shenavandeh; Zahra Habibagahi; Behrouz Gharesi-Fard; Eskandar Kamali-Sarvestani

Volume 9, Issue 4 , Autumn 2012, , Pages 241-247

  Background: The prevalence of anti-Neutrophil Cytoplasmic Antibodies (ANCAs) and anti-Cardiolipin Antibodies (anti-CL Ab) in Behcet’s Disease (BD) and also their roles in vascular involvement is controversial. Objective: To assess the prevalence of ANCAs and anti-CL Ab as well as their correlations ...  Read More

2. Anticardiolipin and Antibeta2glycoproteinI Antibodies in Patients with Hepatitis B and C Infections

Zahra Habibagahi; Mohammad Ali Nazarinia; Elham Aflaki; Akbar Rajaee

Volume 4, Issue 3 , Autumn 2007, , Pages 161-166

  Background: The clinical significance of antiphospholipid antibodies in patients with chronic hepatitis C virus (HCV) and some other viral infections is controversial. Objective: To study the prevalence of anticardiolipin antibody (ACLA) and antibeta2glycoproteinI antibody (antibeta2GPI antibody) in ...  Read More

3. Anticardiolipin Antibody in Patients with Behçet's Disease with and without Vascular Thrombosis

Akbar Rajaee; Mohammad Ali Nazarinia; Seyed Modjtaba Hakim; Mitra Amini; Maryam Ayatollahi; Abbas Ghaderi

Volume 1, Issue 2 , Summer 2004, , Pages 111-117

  Objective: The clinical value of IgG anticardiolipin antibody in patients with Behçet's disease with or without vascular thrombosis was evaluated.   Methods: IgG isotype of anticardiolipin (aCL) antibody was assessed in 40 Behçet's disease (BD) patients with venous or arterial thrombosis, ...  Read More